Change in body mass index and insulin resistance after 1-year treatment with gonadotropin-releasing hormone agonists in girls with central precocious puberty
PurposeGonadotropin-releasing hormone agonist (GnRHa) is used as a therapeutic agent for central precocious puberty (CPP); however, increased obesity may subsequently occur. This study compared body mass index (BMI) and insulin resistance during the first year of GnRHa treatment for CPP.MethodsPatie...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Korean Society of Pediatric Endocrinology
2017-03-01
|
| Serie: | Annals of Pediatric Endocrinology & Metabolism |
| Soggetti: | |
| Accesso online: | http://e-apem.org/upload/pdf/apem-22-27.pdf |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|